E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Following the FDA clearance, Traferox will begin making 10°C heart preservation available to transplant centres across the United States.
imphoenix82
Ready-to-use indocyanine green injection Zyogreen is marketed and distributed in the US by Sagent under an agreement with French pharmaceutical company Provepharm.
imphoenix82
The regulator has advised the public, healthcare professionals, pharmacists, retailers and healthcare institutions to ensure NSAIDs and antibiotics are used only when clinically indicated, at the appropriate dose and duration, and under medical supervision.
imphoenix82
The FDA IDE approval allows Mercy BioAnalytics to initiate a prospective clinical study to evaluate the safety of the ovarian cancer screening test in average-risk women, following Institutional Review Board (IRB) approval.
imphoenix82
BoomRay will receive up to USD 900 million, comprising an upfront payment and development, regulatory and sales milestone payments from Novartis.
imphoenix82
Dr. Reddy’s Laboratories and Takeda have entered into a distribution agreement to promote and distribute QDENGA, Takeda’s dengue vaccine, across India’s private market for paediatric and adult vaccination. Subject to completion of applicable processes with local authorities, the vaccine is expected to become available in India in the first half of 2027. The partnership follows […]
imphoenix82
ITM’s late-stage pipeline is expected to complement Telix’s existing portfolio and includes ITM-11, a novel therapeutic candidate for the treatment of gastroenteropancreatic neuroendocrine tumours (GEP-NETs).
imphoenix82
Speaking to Health Xplore on the sidelines of iPHEX 2026, Dr Shipra Pandey, Deputy Manager – International Business Development, Ratnatris Pharmaceuticals, discusses the company’s international expansion plans, expectations of foreign buyers, India’s dependence on Chinese APIs, and more.
dineshwori
Speaking to Health Xplore at iPHEX 2026, Jaydeep Rathod of Zota Healthcare discusses the key barriers preventing Indian pharmaceutical manufacturers from investing in R&D and innovation and the need for greater industry collaboration.
imphoenix82
The Eros Wellness Preventive Health Platform provides more than 60 health and wellness data points through AI-powered facial scan and connected health measurements.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
